Abstract
Overexpression of cyclin D1 in head and neck cancer has been suggested to be a poor prognostic factor. To understand the role of cyclin D1 expression in head and neck cancer, we overexpressed cyclin D1 in TU182 (a cell line derived from pharyngeal cancer) using a retroviral vector. Stable transfectants were isolated by neomycin (G418) selection. Compared to the parental and control-vector transfected cells, the cyclin D1 transfected cells revealed a decrease of the G1/G0 population and resulted in continuous proliferation under low serum conditions. Proliferation assays revealed an increase in resistance to cisplatin in cyclin D1 overexpressing cells. These observation suggest that deregulation of cyclin D1 may reduce growth factor requirements and contribute to the resistance to some chemotherapeutic agents among head and neck cancer patients.
Similar content being viewed by others
References
Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG (1994) PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74:152–158
Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M, Cesana BM, Pignataro L (2000) Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 22:234–240
Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, El-Naggar A, Hong WK, Hittelman WN (1998) Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene 17:2313–2322
Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.Cancer Res 54:4813–4817
Kornmann M, Danenberg KD, Arber N, Beger HG, Danenberg PV, Korc M (1999) Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res 59:3505–3511
Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL (1994) Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54:3662–3667
Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S (1996) Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer 78:390–395
Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55:975–978
Nakashima T, Clayman GL (2000) Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 126:957–961
Sherr CJ (1993) Mammalian G1 cyclins. Cel. 73:1059-1065
Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551–555
Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60:3689–3695
Rousseau A, Lim MS, Lin Z, Jordan RC (2001) Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. Oral Oncol 37:268–275
Wang MB, Yip HT, Srivatsan ES (2001) Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin. Laryngoscope 111:982–988
Zwijsen RM, Klompmaker R, Wientjens EB, Kristel PM, van der Burg B, Michalides RJ (1996) Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol Cell Biol 16:2554–2560
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakashima, T., Kuratomi, Y., Yasumatsu, R. et al. The effect of cyclin D1 overexpression in human head and neck cancer cells. Eur Arch Otorhinolaryngol 262, 379–383 (2005). https://doi.org/10.1007/s00405-004-0831-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-004-0831-z